AnGes, Inc. (4563.T)
JPY 66.0
(1.54%)
JPY 66.0
(1.54%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | -8.86 Billion JPY | 33.97% |
| 2022 | -13.41 Billion JPY | -2.51% |
| 2021 | -13.2 Billion JPY | -97.51% |
| 2020 | -4.18 Billion JPY | -136.0% |
| 2019 | -3.26 Billion JPY | 10.89% |
| 2018 | -3.05 Billion JPY | -11.63% |
| 2017 | -3.25 Billion JPY | 41.0% |
| 2016 | -4.69 Billion JPY | -17.04% |
| 2015 | -4.12 Billion JPY | -83.58% |
| 2014 | -2.22 Billion JPY | -73.88% |
| 2013 | -1.3 Billion JPY | 20.34% |
| 2012 | -1.6 Billion JPY | 4.17% |
| 2011 | -1.69 Billion JPY | 2.96% |
| 2010 | -1.84 Billion JPY | 14.78% |
| 2009 | -2.48 Billion JPY | -41.77% |
| 2008 | -2.45 Billion JPY | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q1 | -1.66 Billion JPY | 11.64% |
| 2024 Q2 | -1.75 Billion JPY | -5.03% |
| 2023 Q1 | -3.04 Billion JPY | 1.11% |
| 2023 Q4 | -1.92 Billion JPY | 56.58% |
| 2023 Q2 | -1.74 Billion JPY | 42.74% |
| 2023 FY | - JPY | 33.97% |
| 2023 Q3 | -4.43 Billion JPY | -154.44% |
| 2022 Q2 | -3.87 Billion JPY | -9.43% |
| 2022 Q4 | -3.07 Billion JPY | 37.54% |
| 2022 Q1 | -3.54 Billion JPY | -2.61% |
| 2022 FY | - JPY | -2.51% |
| 2022 Q3 | -4.92 Billion JPY | -27.01% |
| 2021 Q2 | -3.96 Billion JPY | -17.41% |
| 2021 Q4 | -3.45 Billion JPY | 26.68% |
| 2021 FY | - JPY | -97.51% |
| 2021 Q3 | -4.7 Billion JPY | -18.63% |
| 2021 Q1 | -3.38 Billion JPY | 10.16% |
| 2020 Q4 | -3.76 Billion JPY | -244.18% |
| 2020 Q2 | -797.36 Million JPY | 18.59% |
| 2020 Q1 | -979.39 Million JPY | -18.04% |
| 2020 Q3 | -1.09 Billion JPY | -37.12% |
| 2020 FY | - JPY | -136.0% |
| 2019 Q1 | -678.57 Million JPY | 20.35% |
| 2019 FY | - JPY | 10.89% |
| 2019 Q3 | -506.93 Million JPY | 36.59% |
| 2019 Q2 | -799.48 Million JPY | -17.82% |
| 2019 Q4 | -829.73 Million JPY | -63.68% |
| 2018 Q2 | -626.93 Million JPY | 2.51% |
| 2018 Q1 | -643.05 Million JPY | 7.28% |
| 2018 Q3 | -1.03 Billion JPY | -65.34% |
| 2018 FY | - JPY | -11.63% |
| 2018 Q4 | -851.92 Million JPY | 17.81% |
| 2017 Q2 | -554.44 Million JPY | 0.8% |
| 2017 FY | - JPY | 41.0% |
| 2017 Q4 | -693.51 Million JPY | 33.63% |
| 2017 Q3 | -1.04 Billion JPY | -88.47% |
| 2017 Q1 | -558.89 Million JPY | 48.4% |
| 2016 Q4 | -1.08 Billion JPY | -12.31% |
| 2016 Q3 | -964.31 Million JPY | 40.2% |
| 2016 Q2 | -1.61 Billion JPY | -35.39% |
| 2016 Q1 | -1.19 Billion JPY | -3.16% |
| 2016 FY | - JPY | -17.04% |
| 2015 Q2 | -1.04 Billion JPY | -8.73% |
| 2015 FY | - JPY | -83.58% |
| 2015 Q1 | -960.69 Million JPY | -404.23% |
| 2015 Q3 | -1.06 Billion JPY | -2.18% |
| 2015 Q4 | -1.15 Billion JPY | -8.17% |
| 2014 Q1 | -476.3 Million JPY | -14.74% |
| 2014 FY | - JPY | -73.88% |
| 2014 Q2 | -559.57 Million JPY | -17.48% |
| 2014 Q4 | -190.52 Million JPY | 81.24% |
| 2014 Q3 | -1.01 Billion JPY | -81.53% |
| 2013 Q4 | -415.1 Million JPY | -32.53% |
| 2013 FY | - JPY | 20.34% |
| 2013 Q3 | -313.21 Million JPY | -0.79% |
| 2013 Q2 | -310.76 Million JPY | -3.09% |
| 2013 Q1 | -301.45 Million JPY | 3.0% |
| 2012 Q2 | -445.13 Million JPY | 13.21% |
| 2012 Q4 | -310.77 Million JPY | 28.05% |
| 2012 Q3 | -431.95 Million JPY | 2.96% |
| 2012 FY | - JPY | 4.17% |
| 2012 Q1 | -512.88 Million JPY | 12.66% |
| 2011 Q4 | -587.21 Million JPY | -62.84% |
| 2011 Q1 | -588.32 Million JPY | -62.9% |
| 2011 Q2 | -402.82 Million JPY | 31.53% |
| 2011 Q3 | -360.6 Million JPY | 10.48% |
| 2011 FY | - JPY | 2.96% |
| 2010 Q1 | -473.03 Million JPY | 2.51% |
| 2010 Q2 | -462.62 Million JPY | 2.2% |
| 2010 Q4 | -361.15 Million JPY | 16.35% |
| 2010 Q3 | -431.74 Million JPY | 6.67% |
| 2010 FY | - JPY | 14.78% |
| 2009 Q3 | -617.44 Million JPY | -235.68% |
| 2009 FY | - JPY | -41.77% |
| 2009 Q2 | -183.94 Million JPY | 75.2% |
| 2009 Q4 | -485.18 Million JPY | 21.42% |
| 2009 Q1 | -741.75 Million JPY | 0.0% |
| 2008 FY | - JPY | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| KOHJIN BIO CO LTD | 958.1 Million JPY | 1024.745% |
| PRISM BioLab Co.,LTD | -488.13 Million JPY | -1715.083% |
| GNI Group Ltd. | 14.48 Billion JPY | 161.151% |
| Linical Co., Ltd. | 1.24 Billion JPY | 810.372% |
| Trans Genic Inc. | 240.95 Million JPY | 3777.081% |
| MEDINET Co., Ltd. | -1.35 Billion JPY | -553.462% |
| Soiken Holdings Inc. | -583.2 Million JPY | -1419.189% |
| Cytori Cell Research Institute, Inc. | -603.09 Million JPY | -1369.098% |
| OncoTherapy Science, Inc. | -1.28 Billion JPY | -589.23% |
| Nxera Pharma Co., Ltd. | -7.39 Billion JPY | -19.746% |
| Immuno-Biological Laboratories Co., Ltd. | 128.1 Million JPY | 7016.094% |
| NanoCarrier Co., Ltd. | -863 Million JPY | -926.651% |
| Carna Biosciences, Inc. | -1.09 Billion JPY | -711.517% |
| CanBas Co., Ltd. | 53.65 Million JPY | 16614.138% |
| D. Western Therapeutics Institute, Inc. | -775.59 Million JPY | -1042.355% |
| RaQualia Pharma Inc. | -111.8 Million JPY | -7824.795% |
| Chiome Bioscience Inc. | -1.21 Billion JPY | -631.182% |
| Kidswell Bio Corporation | -1.38 Billion JPY | -541.647% |
| PeptiDream Inc. | 7.37 Billion JPY | 220.118% |
| Oncolys BioPharma Inc. | -1.92 Billion JPY | -359.141% |
| Ribomic Inc. | -1.01 Billion JPY | -775.039% |
| SanBio Company Limited | -4.52 Billion JPY | -95.801% |
| Healios K.K. | -3 Billion JPY | -194.646% |
| BrightPath Biotherapeutics Co., Ltd. | -1.16 Billion JPY | -660.002% |
| Kubota Pharmaceutical Holdings Co., Ltd. | -1.39 Billion JPY | -536.006% |
| Delta-Fly Pharma, Inc. | -1.4 Billion JPY | -531.954% |
| StemRIM | -2.03 Billion JPY | -336.024% |
| CellSource Co., Ltd. | 1.3 Billion JPY | 778.179% |
| FunPep Company Limited | -952 Million JPY | -830.672% |
| Kringle Pharma, Inc. | -888.76 Million JPY | -896.892% |
| Stella Pharma Corporation | -723.85 Million JPY | -1124.004% |
| TMS Co., Ltd. | -937 Million JPY | -845.571% |
| Noile-Immune Biotech Inc. | -775.39 Million JPY | -1042.649% |
| Cuorips Inc. | -518 Million JPY | -1610.425% |
| K Pharma,Inc. | 366.05 Million JPY | 2520.381% |
| Takara Bio Inc. | 8.02 Billion JPY | 210.419% |
| ReproCELL Incorporated | 8.24 Million JPY | 107559.066% |
| PhoenixBio Co., Ltd. | 87.93 Million JPY | 10175.28% |
| StemCell Institute Inc. | 534.35 Million JPY | 1758.077% |
| Japan Tissue Engineering Co., Ltd. | 244.81 Million JPY | 3719.074% |
| CellSeed Inc. | -836.51 Million JPY | -959.155% |